Diabetes is one of the most common long-term health conditions in the world. Millions of people live with the disease every day, and the number continues to rise. Diabetes occurs when the body cannot properly control blood sugar levels.
Over time, high blood sugar can damage blood vessels and important organs, increasing the risk of heart disease, kidney failure, nerve damage, vision loss, and other serious complications.
For this reason, keeping blood sugar under control is one of the most important goals of diabetes treatment. Along with healthy eating, regular exercise, and weight management, many people need medication to help manage their condition.
In recent years, a newer group of diabetes medications known as SGLT2 inhibitors has become increasingly popular. These drugs work differently from many older diabetes treatments.
Instead of helping the body produce more insulin or use insulin more effectively, they lower blood sugar by causing the kidneys to remove excess glucose from the bloodstream. The extra sugar is then passed out of the body through urine.
This unique approach has made SGLT2 inhibitors an attractive treatment option for many patients.
Research has shown that these medications can help lower blood sugar levels, support weight loss, and in some cases reduce the risk of heart-related complications. Because of these benefits, doctors around the world have prescribed them to millions of people with type 2 diabetes.
However, a study conducted by scientists at the U.S. Food and Drug Administration has raised concerns about a rare but potentially life-threatening side effect associated with these drugs.
The researchers investigated cases of a severe infection called Fournier gangrene in people taking SGLT2 inhibitors. Fournier gangrene is a rare but extremely serious bacterial infection that affects the tissues around the genital and anal regions. The infection spreads rapidly and destroys soft tissue, making it a medical emergency.
Without prompt treatment, the infection can become life-threatening. Patients often require hospitalization, powerful antibiotics, and surgery to remove damaged tissue. In severe cases, multiple surgeries may be needed to control the infection and prevent further complications.
The FDA researchers reviewed medical reports collected between 2013 and 2019. During this period, they identified 55 cases of Fournier gangrene in patients who were using SGLT2 inhibitors. The affected individuals ranged from young adults to elderly patients, and both men and women developed the infection.
The timing of the illness varied considerably. Some patients developed symptoms within only a few days of starting the medication, while others became ill after using the drugs for several years. Many of the patients also experienced other serious diabetes-related health problems, including severe infections, kidney injury, and diabetic ketoacidosis.
Diabetic ketoacidosis is a dangerous condition that occurs when the body does not have enough insulin and begins breaking down fat too quickly. This process leads to a buildup of acids called ketones in the bloodstream and can become life-threatening if not treated quickly.
To better understand whether this risk was specifically linked to SGLT2 inhibitors, the researchers compared the findings with reports involving older diabetes medications such as insulin and metformin. They found that over many decades of use, far fewer cases of Fournier gangrene had been reported among patients using these traditional treatments.
Although the infection remains very uncommon, this difference suggested that people taking SGLT2 inhibitors may face a higher risk compared with those using older diabetes medications.
The study does not mean that patients should stop taking these drugs. In fact, health experts stress that SGLT2 inhibitors continue to provide important benefits for many people. For some patients, these medications improve blood sugar control, reduce body weight, and lower the risk of heart and kidney complications.
Instead, the findings highlight the importance of awareness and early detection. Because Fournier gangrene can progress very quickly, recognizing symptoms as soon as possible can make a major difference in treatment outcomes.
Doctors are being encouraged to monitor patients carefully, particularly during the first weeks and months after starting therapy. Patients should also understand the warning signs and seek immediate medical attention if they develop unusual symptoms.
Possible symptoms include pain, tenderness, swelling, redness, warmth, or discomfort around the genital or anal area. Fever, feeling unwell, or other signs of infection should also be taken seriously. Quick medical evaluation is critical because delays in treatment can allow the infection to spread rapidly.
The study also serves as a reminder that all medications have both benefits and risks. Even treatments that provide substantial health improvements can occasionally cause rare side effects. This is especially true for newer medications that have not been used as long as older therapies.
Researchers and health agencies continue to monitor the safety of SGLT2 inhibitors as more patients use them. Ongoing studies will help doctors better understand which patients may be at greatest risk and how these complications can be prevented.
The findings emphasize the importance of communication between patients and healthcare providers. Patients should never stop taking prescribed medications without consulting their doctor. Instead, they should discuss any concerns, understand potential side effects, and know when to seek medical attention.
Overall, the FDA study highlights the need to balance the significant benefits of SGLT2 inhibitors against their potential risks. While Fournier gangrene remains a very rare complication, awareness of the condition may help ensure that patients receive prompt treatment if symptoms occur.
By staying informed and working closely with healthcare professionals, people with diabetes can continue to manage their condition safely while minimizing the risk of serious complications.
The research was conducted by scientists at the U.S. Food and Drug Administration and contributed to ongoing efforts to improve the safe use of diabetes medications.
If you care about diabetes, please read studies about bananas and diabetes, and honey could help control blood sugar.
For more health information, please see recent studies about Vitamin D that may reduce dangerous complications in diabetes and plant-based protein foods may help reverse type 2 diabetes.
Copyright © 2026 Knowridge Science Report. All rights reserved.
